PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Am J Reprod Immunol. Author manuscript; available in PMC Feb 22, 2011.
Published in final edited form as:
PMCID: PMC3042548
NIHMSID: NIHMS208603
Evolution of non-cytotoxic uterine natural killer (uNK) cells
Satyan Kalkunte,1 Clinton O. Chichester,2 Francesca Gotsch,4 Charles L. Sentman,3 Roberto Romero,4 and Surendra Sharma1
1 Department of Pediatrics, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA
2 Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI, USA
3 Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH, USA
4 Perinatology Research Branch, National Institute of Child Health and Human Development (NICHD), Detroit, MI, USA
Correspondence: Surendra Sharma, MD, Ph.D., Department of Pediatrics, Women and Infants Hospital, Warren Alpert Medical School of Brown University, 101 Dudley Street, Providence RI 02905 USA, ssharma/at/wihri.org
The immune tolerance and de novo vascularization are two highly intriguing processes at the maternal-fetal interface that appear to be central for normal pregnancy outcome. Immune tolerance occurs despite the local presence of an active maternal immune system including macrophages, dendritic cells and specialized CD56brightCD16 uterine NK cells (65–70%). Recent observations indicate that the phenotypic and functional repertoire of uNK cells is distinct from peripheral blood NK (pNK) and endometrial NK cells (eNK) cells, challenging the understanding of their temporal occurrence and function. Origin and specialized programming of uNK cells continue to be debated. uNK cells, replete with an armamentarium to kill the foreign, tolerate the conceptus and facilitate pregnancy. Why do these uNK cells remain non-cytotoxic? Are these NK cells “multitasking” in nature harboring beneficial and detrimental roles in pregnancy? Are there distinct subpopulations of NK cells that may populate the decidua? We propose that the endometrium/decidua functions as an “inducible tertiary lymphoid tissue” that supports the recruitment and expansion of CD56brightCD16 NK cells, and induces transcriptional up-regulation of angiogenic machinery in response to exposure to local hormonal factors, cytokine milieu and perhaps hypoxia. The angiogenic features of uNK cells could further result in a “multitasking” phenotype that still remains to be characterized. This paper discusses the factors and pathways that bridge the angiogenic and non-cytotoxic response machineries at the maternal-fetal interface.
Keywords: Angiogenic factors, Decidua, Inducible tertiary lymphoid tissue, Natural killer cells, Non-cytotoxicity, Pregnancy
Pregnancy is a dynamic process that triggers adaptation by the maternal immune, vascular, and hormonal systems. Immune cellular accumulation in the non-pregnant endometrium parallels its programming as a “tertiary lymphoid organ” which may provide an inflammatory impetus required for blastocyst implantation.1,2 Establishment of pregnancy interrupts the menstrual cycle and creates a local hypoxic environment for placentation, early embryo and fetal development.
This evolutionary adaptation is addressed by remodeling of the maternal spiral arteries associated with loss of normal musculo-elastic structure, converting the spiral arteries into large, thin-walled, dilated vessels of minimum resistance.3 These changes are associated with unique homing to and/or expansion of maternal NK cells in the decidua. Interestingly, uNK cells peak and constitute the largest leukocyte population during the early pregnancy period accounting for about 70% of total mononuclear population but dwindle as the pregnancy proceeds.4
Human NK cells that populate various peripheral blood, lymphoid and non-lymphoid organs originate from CD34+IL-2Rβ-chain+ hematopoietic stem cell progenitors.5 Depending on their residential organ, subtle but distinct phenotypic and functional differences are observed. pNK cells constitute about 8–10% of the peripheral blood mononuclear cell (PBMC) population in the circulation. The majority of NK cells are characterized by the lack of CD3 and the presence of CD56 antigens. Based on the intensity of CD56 antigen, NK cells are further divided into CD56bright and CD56dim populations. The presence or absence of FcγRIII or CD16 further differentiates subpopulations of NK cells. Thus, the majority of pNK cells are of the CD56dimCD16+ phenotype while the remaining belongs to the CD56brightCD16 phenotype. In lymph nodes, NK cells predominantly express CD56brightCD16.1,6 In the female reproductive tract, the majority of endometrial NK cells (eNK) and NK cells from the cervix and fallopian tube are of CD56brightCD16CD9+CD94+ phenotype. On the other hand, in the ectocervix and vagina, NK cells express CD56dimCD16+CD9+CD94.6 As shown in Figure 1, the uNK cell number cyclically increases and decreases in tandem with the menstrual cycle - low in the proliferative phase, increases during early-, mid- and late-secretory phases, falling to basal level during menstruation. With successful implantation, the NK cell population further increases in the decidualized endometrium and reaches peak during first trimester and dwindle thereafter by the end of second trimester.7 A similar kinetics of uNK cells characterized by typical NK cell phenotypic markers exists in rodents during pregnancy. However unlike humans, in non-pregnant mouse endometrium, granulated NK cells are almost absent. In mouse, NK cells are identified by NK1.1 and DX5 phenotypic markers. Comparative surface profiles of antigens, natural cytotoxicity receptors, chemokine and growth factor receptors on human pNK, eNk and uNK cells are provided in the Table 1. Further, CD56bright uNK cells are different from the CD56bright minor population of pNK cells based on the expression of CD9, CD103, and killer immunoglobulin-like receptors (KIR).8,9 Replete with a cytotoxic arsenal of perforin, granzymes A and B, and the receptors NKp30, NKp44, NKp46, NKG2D, uNK cells remain tolerant cytokine producing cells at the maternal-fetal interface.10
Figure 1
Figure 1
Biological rhythm of CD56brightNK cells in the human endometrium and the decidua
Table 1
Table 1
Expression of surface markers and receptors on NK cells
The origin of uNK cells that peak during the secretory phase of luteal cycle and early pregnancy is not well established and evidence indicates multiple different possibilities.
Conscription of CD56brightCD16 pNK cells
The notion of recruitment from peripheral blood CD56brightCD16 NK cells to the endometrium and decidua is based on the fact that these cells express L-selectin and chemokine receptor CXCR4 that can home towards its ligand CXCL12 found on the extravillous trophoblasts within the decidua.11,12 However, the presence of conceptus is not required for the increase in CD16 NK cells during the secretory phase of luteal cycle.7 Nevertheless, in the non-pregnant uterus, progesterone and estrogen may support the migration of CXCR3 positive CD56bright pNK cells by augmenting the expression of CXCL10 and CXCL11 in the endometrium.13,14
CD56dimCD16+ pNK cells as migratory precursors
Recruitment of CD56dimCD16+ pNK cells to estrogen or progesterone rich chemokine expressing endometrium is also possible. It has been recently reported that TGFβ produced by the decidual stromal cells can convert the CD56dimCD16+ NK cells to CD56brightCD16 NK cells, indicating tissue specific terminal differentiation.15 However, this may be an induced reversible process because CD56brightCD16 NK cells may be precursor for CD56dimCD16+ NK cells. In addition, in vitro conversion of CD56dimCD16+ NK cells to CD56brightCD16 NK cells appear to be a complex process and may not follow recruitment and appearance.
Progenitor cells as source of uNK cells
It is widely recognized that the bone-marrow microenvironment provides a rich source of cytokines and growth factors that can support NK-cell developmentand maturation in the presence of stromal cells.5 Similar to the bone-marrow, the endometrium may provide appropriate a local micro-environment to support NK cell development. A minor population (0.1%) of LinCD34+CD45+ cells is present in the decidua that can differentiate into CD56brightCD16 NK cells in response to stromal cell-derived factors, interleukin-15 and stem-cell factor during a 30 day culture period.15 However, a caveat with these observations is that many of the factors that allow this to happen have not been shown to be present in the endometrium. Nevertheless, animal studies reveal that infusion of bone-marrow cells to tgε26 mice which, are devoid of NK cells, repopulate the uNK cell pool.16 uNK cells may then proliferate in situ by up-regulating the suitable gene cascade to reach the peak numbers.17,18
Seeding and Expansion of CD56brightCD16 NK cells
The hormonal milieu-driven “seeding and expansion” of resident CD56brightCD16 NK cells is thought to have a major influence on the evolution of these cells in the endometrium and the decidua. In situ expansion and proliferation is possible as CD56brightCD16 NK cells express prolactin, estrogen β and glucocorticoid receptors despite the lack of progesterone receptors.19,20 Progesterone, hCG, prolactin may act indirectly to prime stromal cells or to act directly on NK cells through glucocorticoid receptors and membrane potassium channels supporting proliferation of CD56brightCD16 NK cells (Figure 2). 21,22 Additionally, progesterone may modulate CD56brightCD16 NK cell cytotoxicity possibly through progesterone-induced blocking factor (PIBF) and support angiogenesis.23, 24
Figure 2
Figure 2
Hormone-cytokine influence on evolution and function of uNK cells
Endometrium/decidua as “inducible tertiary lymphoid” tissue
Unlike the canonical secondary lymphoid organs, “tertiary lymphoid tissues” are patterned as a result of accumulations of lymphoid cells through a process called “lymphoid neo-vascularization”. Such extra-thymic temporal lymphoid tissues are known to occur in autoimmunity, microbial infections and chronic allograft rejection.5,25,26 Like any mucosal tissue, many myeloid and lymphoid cell aggregates are found in non-pregnant uterus.26,27 It is long thought that CD56brightCD16 NK cells are precursors of CD56dimCD16+ NK cells, and unlike the ratios of these two phenotypic populations in blood, these cells are predominantly CD56brightCD16 in lymph nodes. A plethora of evidence supports this notion: a) Shortly after bone-marrow transplantation, the CD56brightCD16 cell population increases and then tapers off when CD56dimCD16+ cells become prominent,27 b) The telomere length is shorter in CD56dimCD16+ compared to CD56brightCD16 cells from the same donor, supporting the precursor role of CD56brightCD16 cells as telomeres progressively shorten with growth and differentiation,28 and c) CD56bright cells can differentiate into CD56dim both in vitro, in the presence of synovial fibroblasts, and in vivo, upon transfer into NOD-SCID mice.29 It is tempting to speculate that hormonal milieu during menstrual cycle or implantation, converts the endometrium or decidua into an inducible “tertiary lymphoid tissue” that recruits and amplifies circulating CD45+CD34+ hematopoietic progenitor cells and CD56brightCD16 NK cells (Figure 3). The progenitor cells, in response to surrounding uterine stromal tissue and IL-15, differentiate into CD56brightCD16 NK cells and express angiogenic factors, L-selectin and CCR7 that program them to adhere to the tissue. Hypoxia caused by the implanted and rapidly developing embryo may further stimulate angiogenic signals and chemokine expression in uNK cells to recruit invading trophoblasts. On the other hand, lack of pregnancy compatible intrauterine milieu (e.g. absence of IL-10, VEGF, Stromal Cell Protein (SCP), hCG, etc) or the presence of intrauterine infections may allow further maturation and differentiation into cytotoxic CD56dimCD16+ NK cells triggering pregnancy complications.
Figure 3
Figure 3
Origin of uNK cells-endometrium and decidua as “inducible tertiary lymphoid tissue”
The predominant population of CD56brightCD16 uNK cells in the decidua directly places them in close proximity with decidual stromal cells, maternal endothelial cells and extravillous trophoblasts. This should favor cell-cell cross-talk and interaction. Two hallmarks of activated pNK cells, the expression of natural cytotoxicity receptors and their ability to lyse targets that are deficient in major histocompatability complex (MHC) presentation, are also the intrinsic features of uNK cells. Interestingly, unlike pNK cells, uNK cells remain non-cytotoxic and produce regulatory cytokines and growth factors that support normal pregnancy. Thus, the question that should be asked here is whether the angiogenic machinery programmed in uNK cells is responsible for their non-cytotoxic activity during pregnancy.
Non-cytotoxic uNK cells as angiogenesis promoters
In situ hybridization studies with non-pregnant endometrium localized mRNA for VEGF-C, PlGF, Ang 2 to NK cells. VEGF-C was shown to peak during the early and mid secretory phase of the cycle reflecting the inherent nature of NK cell phenotypes found in endometrium.30 Other studies have shown that unlike pNK cells, uNK cells are a major source of VEGF-C, Ang1, Ang2 and TGFβ1 within the placental bed that decrease with gestational age implicating uNK cells in promoting angiogenesis.31 Studies have provided further evidence that uNK cells, but not pNK cells, regulate trophoblast invasion both in vitro and in vivo through the production of interleukin-8 and interferon-inducible protein-10 (IP-10) in addition to other of angiogenic factors.32 Increased serum levels of IP-10 have been implicated for the poor angiogenesis seen in pre-eclampsia.33 Our own unpublished observations indicate that eNK cells and uNK secrete variable amounts of VEGF-A, VEGF-C and IFNγ and express of natural cytotoxicity receptors (NCR), implying that empowerment of uNK cells with the angiogenic features keeps them non-cytotoxic.34 Both hypoxia and a low pH associated with tumors have been shown to suppress NK cell cytotoxicity and increase the resistance of tumor cells.35,36 Factors that trigger this angiogenesis-non-cytotoxicity axis of uNK cells are not yet clear, however, we propose transformation of endothelial cells and trophoblasts regulated by uNK cells.
Can uNK cells become foes to pregnancy?
Although the origin and temporal appearance of uNK cells is not yet clear, recent reports have implicated cytotoxic uNK cells in the pathogenesis of subgroup of spontaneous abortions and implantation failures. Spontaneous abortion is associated with an increase in CD56dimCD16+ cells and a decrease in CD56brightCD16 NK cells in the pre-implantation endometrium during the luteal phase.37,38 A fine balance between maternal activating and inhibitory killer IgG-like receptors (KIR) and their ligand human leukocyte antigen C (HLA-C) on fetal cells seems to be maintained in normal pregnancy. Insufficient inhibition of uNK cells can turn on the cytolytic machinery causing spontaneous abortions.39 In the setting of IVF, the implantation failure has been associated with high uNK cell numbers but direct evidence for their role in abnormal implantation is not clear.37 These observations raise an important question whether uNK cells can harm fetal tissue and if yes, under what conditions?
The anti-inflammatory cytokine IL-10 plays a critical role in pregnancy because of its regulatory relationship with other intrauterine modulators and its wide range of immunosuppressive activities.40 Significantly, itslocal production by gestational tissues is well documented. We have demonstrated that IL-10 expression by the human placenta was gestational age-dependent, with significant expression through the second trimester followed by attenuation at term.41,42 IL-10 expression was also found to be poor in decidual and placental tissues from unexplained spontaneous abortion cases,42 andfrom deliveries associated with preterm labor 43 and pre-eclampsia (our unpublished observations). However, the mechanism(s) by which IL-10 protects the fetus remains poorly understood. IL-10−/− mice suffer no pregnancy defects when mated under pathogen-free conditions.44 It is then plausible that in addition to IL-10 deficiency, an inflammatory insult resulting from genital tract infections, environmental factors, and/or hormonal dysregulation during gestation may lead to adverse pregnancy outcomes. Our recent studies provided direct evidence that uterine NK (uNK) cells became adversely activated and mediated fetal demise and preterm birth in response to low doses of LPS, a ligand for Toll-like receptor 4 (TLR). These pathologies were directly associated with uNK cell-derived TNF-α.45 However, the impact of “danger signals” (TLR 4 expression) observed in the placental bed of patients with pre-eclampsia on human uNK cells remains to be explored.46 Nevertheless, our findings strongly imply that uNK cells retain the ability to become foes to pregnancy under the axis of genetic stress and inflammatory trigger.
NK cells in non-pregnant humans have evolved as innate immune defense against pathogenic intrusions. Thus, it seems that the recruitment and copious presence of NK cells is not specific to pregnancy, but is an evolutionary coincidence that occurs in tandem with menstrual cycle. The cytokine rich microenvironment, hormonal milieu, relative hypoxia and interacting cells can recruit and expand circulating NK cells and/or differentiate the progenitor cells to eNK that go on to acquire the uNK cell phenotype observed in the decidualized endometrium mimicking “inducible tertiary lymphoid tissue”. Full maturation to cytotoxic NK cells is possibly prevented by the presence of unique growth factors. In pregnancy, armed with all tools to attack, the uNK cells behave as sentinels, adapt and tolerate the semi-allograft, turning on their roles as friends in a specific decidual microenvironment balancing between attenuated cytotoxicity and increased production of angiogenic growth factors. In response to stimuli that eventually would challenge the very existence of “maternal self”, these uNK cells would turn on the “primordially conserved” cytolysis mechanism, eliminate out the adverse stimulus eventually leading to pregnancy failure as seen in the IL-10 deficient scenario.
Acknowledgments
This work was supported in part by grants P20RR018728 from the NIH and Superfund Basic Research Program Award (P42ES013660) from the NIEHS.
1. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7:344–353. [PubMed]
2. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy--an inflammatory view. Trends Immunol. 2006;27:399–404. [PubMed]
3. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6:584–594. [PubMed]
4. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod. 1991;6:791–798. [PubMed]
5. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol. 2003;3:413–425. [PubMed]
6. Mselle TF, Meadows SK, Eriksson M, Smith JM, Shen L, Wira CR, Sentman CL. Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol. 2007;124:69–76. [PubMed]
7. Kitaya K, Yamaguchi T, Yasuo T, Okubo T, Honjo H. Post-ovulatory rise of endometrial CD16(−) natural killer cells: In situ proliferation of residual cells or selective recruitment from circulating peripheral blood? J Reprod Immunol. 2007;76:45–53. [PubMed]
8. Huntington ND, Vosshenrich CA, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol. 2007;7:703–714. [PubMed]
9. Hanna J, Mandelboim O. When killers become helpers. Trends Immunol. 2007;28:201–206. [PubMed]
10. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, Strominger JL. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA. 2005;102:15563–15568. [PubMed]
11. Hanna J, Wald O, Goldman-Wohl D, Prus D, Markel G, Gazit R, Katz G, Haimov-Kochman R, Fujii N, Yagel S, Peled A, Mandelboim O. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16− human natural killer cells. Blood. 2003;102:1569–1577. [PubMed]
12. Frey C, Packianathan MNB, Fehnigeer TA, Ross ME, Wang WC, Stewart CC, Caliguiri MA, Evans SS. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol. 1998;161:400–408. [PubMed]
13. Sentman CL, Meadows SK, Wira CR, Eriksson M. Recruitment of uterine NK cells. induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol. 2004;173:6760–6766. [PubMed]
14. Kitaya K, Nakayama T, Daikoku N, Fushiki S, Honjo H. Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. J Clin Endocrinol Metab. 2004;89:2470–2476. [PubMed]
15. Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD, Koopman LA, Strominger JL. TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16 NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA. 2007;104:3378–3383. [PubMed]
16. Guimond M, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell deficient tgε26 mice. J Exp Med. 1998;187:217–223. [PMC free article] [PubMed]
17. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol. 2005;42:511–521. [PubMed]
18. Lobo SC, Huang ST, Germeyer A, Dosiou C, Vo KC, Tulac S, Nayak NR, Giudice LC. The immune environment in human endometrium during the window of implantation. Am J Reprod Immunol. 2004;52:244–251. [PubMed]
19. Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56 (+) natural killer cells of the human endometrium. J Clin Endocrinol Metab. 2002;87:2329–2335. [PubMed]
20. Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab. 2003;88:440–449. [PubMed]
21. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26:44–62. [PubMed]
22. Ain R, Dai G, Dunmore JH, Godwin AR, Soares MJ. A prolactin family paralog regulates reproductive adaptations to a physiological stressor. Proc Natl Acad Sci USA. 2004;101:16543–16548. [PubMed]
23. Walter LM, Rogers PA, Girling JE. The role of progesterone in endometrial angiogenesis in pregnant and ovariectomized mice. Reproduction. 2005;129:765–777. [PubMed]
24. Laskarin G, Tokmadzic VS, Strbo N, Bogovic T, Szekeres-Bartho J, Randic L, Podack ER, Rukavina D. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol. 2002;48:201–209. [PubMed]
25. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lympotoxin is lymphoid neogenesis. J Exp Med. 1996;183:1461–1472. [PMC free article] [PubMed]
26. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, Orndorff KA, Gonzalez J, Stern JE, Wira CR. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427–435. [PubMed]
27. Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE. CD16 CD56+ natural killer cells after bone marrow transplantation. Blood. 1992;79:3239–3244. [PubMed]
28. Ouyang Q, Baerlocher G, Vulto I, Lansdorp PM. Telomere length in human natural killer cell subsets. Ann N Y Acad Sci. 2007;1106:240–252. [PubMed]
29. Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, Buckley CD, McMichael A, Enver T, Bowness P. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179:89–94. [PubMed]
30. Li XF, Charnock-Jones DS, Zhang E, Hilby S, Malik S, Day K, Licence D, Bowen JM, Gardner SJ, Grusby MJ, Wagner N, Muller W, Guimond MJ. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metabol. 1997;86:1823–1834. [PubMed]
31. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, Robson SC, Bulmer JN. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80:572–580. [PubMed]
32. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12:1065–1074. [PubMed]
33. Gotsch F, Romero R, Friel L, Kusanovic JP, Espinoza J, Erez O, Than NG, Mittal P, Edwin S, Yoon BH, Kim CJ, Mazaki-Tovi S, Chaiworapongsa T, Hassan SS. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med. 2007;20:777–792. [PMC free article] [PubMed]
34. Sharma S, Murphy S, Hanna N, Berg G, Padbury J, Romero R. A model for uterine NK cells as killer not builders in pregnancy. Am J Reprod Immunol. 2007;57:379–381.
35. Fink T, Ebbesen P, Koppelhus U, Zachar V. Natural killer cell mediated basal and interferon-enhanced cytotoxicity against liver cancer cell is significantly impaired under in vivo oxygen conditions. Scand J Immunol. 2003;58:607–612. [PubMed]
36. Muller B, Fischer B, Kreutz W. An acidic microenvironment impairs the generation on non-major histocompatibility complex restricted killer cells. Immunology. 2000;99:375–384. [PubMed]
37. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod. 1999;14:2386–2391. [PubMed]
38. Michimata T, Ogasawara MS, Tsuda H, Suzumori K, Aoki K, Sakai M, Fujimura M, Nagata K, Nakamura M, Saito S. Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol. 2002;47:196–202. [PubMed]
39. Varla-leftherioti M, Spyropoulou-Vlachou D, Nikou T, Keramitsoglou A, Darlamitsou C, Tsekoura M, Papadimitropoulos V, Lepage C, Balafoutas C, Stavropopulos-Giokas Natural killer (NK) cell receptors repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol. 2003;49:183–191. [PubMed]
40. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. [PubMed]
41. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol. 2000;164:5721–5728. [PubMed]
42. Plevyak M, Hanna N, Mayer S, Murphy S, Pinar H, Fast L, Ekerfelt C, Ernerudh J, Berg G, Matthiesen L, Sharma S. Deficiency of decidual IL-10 in first trimester missed abortion: a lack of correlation with the decidual immune cell profile. Am J Reprod Immunol. 2002;47:242–250. [PubMed]
43. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S. Evidence for interleukin-10-mediated inhibition of cyclo-oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol. 2006;55:19–27. [PubMed]
44. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod. 2004;70:123–131. [PubMed]
45. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol. 2005;175:4084–4090. [PubMed]
46. Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR, Nien JK, Gomez R, Mazor M, Saito S, Abrahams VM, Mor G. Toll-like receptor 4: a potential link between “danger signals,” the innate immune system, and preeclampsia? Am J Obstet Gynecol. 2005;193:921–927. [PubMed]
47. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71:173–183. [PubMed]